| AUC (μ, 95% CI) (%) | Sensitivity (%) | Specificity (%) |
---|
TT | 70.00 (48.66–91.34) | 83.33 | 60.00 |
CFT | 60.67 (34.70–86.63) | 33.33 | 84.00 |
HC | 81.33 (66.57–96.10) | 100.00 | 72.00 |
THF | 73.00 (54.59–91.41) | 83.33 | 56.00 |
CFHF | 73.00 (51.91–94.09) | 66.67 | 76.00 |
ALL | 82.33 (68.04–96.63) | 100.00 | 72.00 |
- TT: the selected genes whose mutations was associated with higher TMB in tumor tissues; CFT: the selected genes whose mutations was associated with higher TMB in cfDNA of LUAD patients; HC: the selected genes whose variation frequencies in tumor tissues and cfDNA were both > 25%; THF: the top five mutation genes in tumor tissues; CFHF: the top five mutation genes in cfDNA of LUAD patients; ALL: all the selected genes above